CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis

Cellular Immunology

Volumn 253, Issue 1-2, 2008, Pages 92-101

  Han, Guang Ming ^a   O'Neil Andersen, Nancy J ^a   Zurier, Robert B ^b   Lawrence, David A ^a  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Regulatory T cell; Rheumatoid arthritis; Suppressive mechanism

Indexed keywords

GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; TNFSF18 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CELL COUNT; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; ADULT; AGE; AGED; CELL CULTURE; CELL SEPARATION; CYTOLOGY; FEMALE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MIDDLE AGED; MONOCYTE; PATHOLOGY;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD28; ANTIGENS, CD3; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS;

EID: 51449116424     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.05.007     Document Type: Article

References (36)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
2. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 (1998) 1969-1980
3. + regulatory T cells. Semin. Immunol. 16 (2004) 89-97
4. Van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., and Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50 (2004) 2775-2785
5. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., and Mauri C. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200 (2004) 277-285
6. Dombrecht E.J., Aerts N.E., Schuerwegh A.J., Hagendorens M.M., Ebo D.G., Van Offel J.F., Bridts C.H., Stevens W.J., and De Clerck L.S. Influence of anti-tumor necrosis factor therapy (Adalimumab) on regulatory T cells and dendritic cells in rheumatoid arthritis. Clin. Exp. Rheumatol. 24 (2006) 31-37
7. + T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33 (2003) 215-223
8. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140 (2005) 360-367
9. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis. Res. Ther. 6 (2004) R335-R346
10. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8 (2007) 277-284
11. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
12. Pillai V., and Karandikar N.J. Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?. Immunol. Lett. 114 (2007) 9-15
13. Shevach E.M., and Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat. Rev. Immunol. 6 (2006) 613-618
14. Ji H.B., Liao G., Faubion W.A., Abadia-Molina A.C., Cozzo C., Laroux F.S., Caton A., and Terhorst C. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172 (2004) 5823-5827
15. + T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment. Immunology. 116 (2005) 134-141
16. high T cell population in SLE patients treated with glucocorticoids. Ann. Rheum. Dis. 65 (2006) 1512-1517
17. + T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence. Clin. Immunol. 119 (2006) 307-316
18. Huan J., Culbertson N., Spencer L., Bartholomew R., Burrows G.G., Chou Y.K., Bourdette D., Ziegler S.F., Offner H., and Vandenbark A.A. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81 (2005) 45-52
19. Balandina A., Lecart S., Dartevelle P., Saoudi A., and Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105 (2005) 735-741
20. Pillai V., Ortega S.B., Wang C.K., and Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123 (2007) 18-29
21. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., and Byrne M.C. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 16 (2002) 311-323
22. Ronchetti S., Nocentini G., Riccardi C., and Pandolfi P.P. Role of GITR in activation response of T lymphocytes. Blood 100 (2002) 350-352
23. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum. 56 (2007) 732-742
24. + T cells in the periphery. Nat. Rev. Immunol. 7 (2007) 231-237
25. Beyer M., and Schultze J.L. Regulatory T cells in cancer. Blood 108 (2006) 804-811
26. + T cells. J. Immunol. 173 (2004) 5008-5020
27. Cardona I.D., Goleva E., Ou L.S., and Leung D.Y. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J. Allergy. Clin. Immunol. 117 (2006) 688-695
28. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212 (2006) 8-27
29. +CD25 T cells. J. Immunol. 179 (2007) 2041-2045
30. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
31. Curiel T.J. Tregs and rethinking cancer immunotherapy. J. Clin. Invest. 117 (2007) 1167-1174
32. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 6 (2005) 353-360
33. + regulatory T cells and for expansion of these cells. J. Immunol. 178 (2007) 2018-2027
34. + regulatory T cells in cancer patients. Blood 107 (2006) 2409-2414
35. + regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J. Clin. Oncol. 24 (2006) 1169-1177
36. Zhang H., Chua K.S., Guimond M., Kapoor V., Brown M.V., Fleisher T.A., Long L.M., Bernstein D., Hill B.J., Douek D.C., Berzofsky J.A., Carter C.S., Read E.J., Helman L.J., and Mackall C.L. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4(+)CD25(+) regulatory T cells. Nat. Med. 11 (2005) 1238-1243